Effect of 3D Regimen on HRQoL for Patients With Hepatitis C Effect of 3D Regimen on HRQoL for Patients With Hepatitis C
This study investigated the impact of a RBV-free ombitasvir/paritaprevir/ritonavir + dasabuvir (3D) regimen on health-related quality of life for HCV patients, both during and after treatment.Liver International
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Gastroenterology | Health | Hepatitis | Hepatitis C | Liver | Norvir | Study | Urology & Nephrology